Drug Profile
Lamivudine/stavudine/nevirapine - Cipla
Alternative Names: Triomune; Triomune Baby (Lamivudine+ Nevirapine+ Stavudine); Triomune Junior (Lamivudine+ Nevirapine+ Stavudine)Latest Information Update: 24 Jul 2015
Price :
$50
*
At a glance
- Originator Cipla
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Nucleosides; Pyridines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors; RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed HIV-1 infections
Most Recent Events
- 09 Feb 2015 Launched for HIV-1 infections in USA (PO)